For Vitiligo and hypopigmentary disorder
Also Available In:
Tolenorm oil is a Proprietary Siddha Medicine which increases melanocyte division and transfers the pigment melanin to the skin which restores its colour.
It is specially formulated with non-polar actives for the treatment of Vitiligo and hypopigmentary problems
Vitiligo, Hypopigmentary conditions
Science of Tolenorm oil
- Augment tyrosinase activity
- Increase dendrite formation in melanocytes
- Transfer melanosomes to keratinocytes
- Apply Tolenorm oil on affected areas. After absorption of oil, optional sun exposure for 3-5 minutes. Apply thrice a day to ensure high bio-availability of active ingredients.
- Continue usage as advised above till total repigmentation.
Each 5ml contains extract of
Wrightia tinctoria - 50mg
Psorolea corylifolia - 50mg
Indigofera tinctoria - 50mg
Piper longum - 50mg
Oleum cocus nucifera-Q.S
Uniqueness of herbs
Psoralea corylifolia: Contains psoralens that accelerates the photoxidation of DOPA and promotes pigmentation.
Wrightia tinctoria: Contains flavonoids, tannins, glycosides and phenolic compounds known to augment healing properties of skin
Indigofera tinctoria: Contains rich source of pigment indigo and is a natural colouring agent.
Piper longum: Piperine promotes melanocyte proliferation and transfers melanin pigment to the skin.
Available as 50 ml and 100ml pet containers.
There are no known contra-indications.
- 170 vitiligo patients were selected for the study (duration 3 years)
- Early repigmentation of 25% was observed in 42% of patients.
- During 2nd year, 75% repigmentation was observed in 71% of patients.
- Complete repigmentation (more than 90%) was observed in 62% of patients in 3rd year.
- 60 patients with various type of vitiligo were studied for 15 months.
- Within 6 months, 50% repigmentation and within 15 months complete repigmentation was observed in the patients.
- B16F10 melanocyte cells were treated with Tolenorm oil to observe its effect on tyrosinase enzyme activity.
- The enzyme activity was found to be significantly increased in treated cells with compared to untreated cells.
The information and details provided on this page is not intended to be an alternative for professional medical advice. Consulting a qualified medical practitioner for diagnosis and regular clinical follow up is recommended.